20 May 2013
Keywords: headlines, years, ago, week, key, pharmaceutical, licenses
Article | 22 May 2006
Key Pharmaceutical licenses its Nitro-Dur to SmithKline Corp for which it will receive an upfront payment of $500,000 plus a further $3.0 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.